SCHEMBL567436

SCHEMBL567436

CC(C=O)N(C)C(=O)OCc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.51
ALDH1A1 P00352 4/20 0.49
CTSB P07858 4/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
HCAR2 Q8TDS4 1/20 0.44
CCR6 P51684 1/20 0.44
PAX8 Q06710 1/20 0.44
MAPK1 P28482 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A3 Q01959 1/20 0.44
KMT2A Q03164 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CTSL P07711 2/20 0.43
CTSS P25774 2/20 0.43
CTSK P43235 2/20 0.43
SIGMAR1 Q99720 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14304888 1.00 ABCB1 (0.51) ABCB1ALDH1A1CTSBMAPTHPGD
SCHEMBL29789557 0.85 ABCB1 (0.49) ABCB1ALDH1A1CTSBMAPTHPGD
SCHEMBL7417025 0.85 ABCB1 (0.49) ABCB1ALDH1A1CTSBMAPTHPGD
SCHEMBL10557878 0.85 ALDH1A1 (0.49) ABCB1ALDH1A1CTSBHCAR2CCR6
SCHEMBL8276259 0.84 ABCB1 (0.56) ABCB1ALDH1A1CTSBMAPTHPGD
SCHEMBL10558457 0.84 ALDH1A1 (0.47) ABCB1ALDH1A1CTSBMAPTHPGD
SCHEMBL6582855 0.83 CTSB (0.49) ABCB1ALDH1A1CTSBMAPTHPGD
SCHEMBL5149951 0.83 ABCB1 (0.58) ABCB1ALDH1A1CTSBMAPTHPGD
SCHEMBL10556602 0.82 ALDH1A1 (0.46) ABCB1ALDH1A1CTSBMAPTHPGD
SCHEMBL7292255 0.82 ALDH1A1 (0.46) ABCB1ALDH1A1CTSBMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2444395-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVE WESTERN THERAPEUTICS INST INC D (JP) 2016-01-06 EP disclosed
US-8951997-B2 Substituted isoquinoline derivative D. WESTERN THERAPEUTICS INSTITUTE, INC. (JP) 2015-02-10 US disclosed
EP-2444395-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVE D. Western Therapeutics Institute, Inc. (JP) 2012-04-25 EP disclosed
US-20120035159-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVE D. WESTERN THERAPEUTICS INSTITUTE, INC (JP) 2012-02-09 US disclosed
US-4367230-A ANTIANOXIC AGENTS TANABE SEIYAKU CO., LTD. (JP) 1983-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035159-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVE SULT1A1, SULT1E1, SULT2A1 ABCB1 1274/4885ALDH1A1 1962/4885CTSB 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.